Evolution of glycated haemoglobin in adults on growth hormone replacement therapy

Conclusions HbA1c values increased during the first 2 years of GHR therapy. In patients with no dysglycaemia before treatment, HbA1c steadily increased over the 3 years. However, it did not change in patients with baseline dysglycaemia.
Source: Endocrinologia y Nutricion - Category: Endocrinology Source Type: research